A presidential address to a learned society or the inaugural address of a professor is usually devoted to one of three possible themes. It can be concerned with political considerations, with a historical survey of some subject, or it can be devoted to a purely scientific problem.
approach with a scientific theme in relation to neurochemistry, and hope to show how in this century progress has been made in this particular field and how there can now be offered applications of the methods, techniques, and theories of the pure neurochemists to clinical medicine and neurology. Therefore the object is rather to show how basic research has frequently been of value at a later date in an understanding of disease processes and subsequently in the treatment of disease. Occasionally this order has had to be reversed and this will also be illustrated.
During the first 50 years of this decade there were 59 medical and physiological Nobel prize winners, and of these some 10 were biochemists or used biochemical methods in the field of neurology. Hence one in every six of all these Nobel prize winners was interested in the field which is under discussion, and some of these workers will be mentioned. Munich in 1928 largely through the activity of Kraepelin, who had been the first to devise a useful classification of schizophrenia. The name of Thudichum is remembered in another way, for I have discovered that in Galesburg in the state of Illinois, U.S.A., a psychiatric research department has named its laboratory after him. It might be worth mentioning now that this Thudichum laboratory, under the direction of Dr. Harold E. Himwich, is the chief psychiatric biochemical research centre in that state, and had officially given to it in 1957 a year's income of some £6,000 more than it is reported our Government gave for psychiatric research for the whole of Great Britain.
Another milestone was reached in 1937 when Page, then in New York, but later in Cleveland, published the volume entitled Chemistry of the Brain. He had worked earlier in Germany and knew many of Germany's prominent biochemists.
The subject of neurochemistry has now expanded well beyond the recognition of these earlier workers, and any general review of the subject is quite obviously impracticable. I have, therefore, chosen only a few major topics to discuss.
Oxidative and Carbohydrate Metabolin The brain has been shown to have a high rate of oxygen utilization. In fact, about 25% of the total oxygen used by the body in basal conditions is utilized by the brain, as was shown relatively recently in 1948 by Kety and Schmidt.
The brain makes use of glucose almost exclusively in its metabolism in contrast to other organs, and by sampling the arterial and the jugular venous blood it has been shown that the respiratory quotient is for practical purposes unity. Naturally, alterations in degrees of consciousness produce some alterations in utilization, and Himwich has made extensive investigations along these lines, and his and other authors' work is discussed in his book entitled Brain Metabolism and Cerebral Disorders.
Oxygen uptake varies from one tissue to another, the order of activity increasing from peripheral nerve to white matter to cerebral cortex. In the same way the trigeminal nucleus has a relatively low activity.
The method by which glucose is metabolized in the brain is very similar to that in other body tissues, following the pathway glucose-6-phosphate, fructose-6-phosphate, and fructose-I: 6-diphosphate to 2 molecules of triosephosphate, and finally to pyruvate. There is then a conversion of pyruvate to a 2 C compound which by a complex reaction can enter the citric acid cycle, which has a close connexion with the Krebs cycle.
These Cerebra Lipids The brain contains some 12% to 15% by wet weight of lipid, or 50% to 60% by dry weight. This fatty material was found by Thudichum to consist largely of cholesterol, sphingomyelin, and cerebroside. Neutral fat is also present but in very small quantities. The early workers used whole human brain and separated the substances on a macro basis with characterization of the component constituents.
Thierfelder, for instance, at the beginning of this century, isolated one of the cerebrosides (cerebron), and 50 years later Chatagnon in Paris, by fresh experimental methods, obtained a substance which gave crystalline appearances and infra-red spectroscopic findings which were similar to those of Thierfelder's original preparation, which was still in existence and with which it was compared.
It is perhaps correct to state that the largest amount of work done on these substances in the human brain has taken place in the last 10 years. Nevertheless, in the 1920s Klenk, Remkamp, Deuel, and others were separating and characterizing many of these compounds on a purely chemical basis. gall-stones, but it was later found that the esterified form of cholesterol did not exist in any appreciable amount in normal brain tissue. Sphingomyelin, so named by Thudichum, was later found to contain a fatty acid which is probably the C 24 lignoceric acid, but it may also be stearic or nervonic acid. Sphingomyelin is closely related to cerebroside as can be seen in Fig. 1 , from which it can be observed that sphingosine is a component part of not only sphingomyelin and cerebroside but also of ganglioside and possibly of a substance called cephalin B.
Klenk and his co-workers around 1940 found a compound in the brain which they named substance X, later renamed ganglioside, and it was shown that it contained neuraminic acid, hexosamine-probably a galactosamine-and a hexose radicle. There is still a good deal of controversy about the exact composition of ganglioside, for slightly varying views from those of Klenk have been expressed by both Svennerholm and Bogoch in the last two years. Klenk is a pure chemist and has built up at Cologne a famous department full of enthusiastic workers who are, however, also interested in disease processes.
Thannhauser and his colleagues in recent years have made important contributions to the chemistry of sphingomyelin and of the plasmalogens, originally described by Feulgen in muscle. He has had much to do with work on various diseases, such as Gaucher's disease and xanthomatosis, while working in America.
The school in Canada led by Rossiter had investigated the brains of normal infants and adults, estimating the relative amounts of sphingomyelin, cerebroside, cholesterol, and lecithin found in the white and grey matter, and their results have been confirmed by Brante in Sweden and also by the group working with me, all within the past 10 years. Just recently, we have been able to add, in an even more extensive series, the results of similar estimations of the various lipids in brains from the foetus, the fullterm infant, the young infant, and the child. Recently a study has been carried out on the water-soluble proteins of the brain. Portions of .cerebral white matter in 5 to 10 g. amounts were extracted with 10 to 20 ml. of 10% sucrose, and similar amounts of cerebral cortex extracted with 5 to 10 ml. quantities of sucrose. The extracts were concentrated, and the proteins present examined by starch electrophoresis. In recent years cerebral metabolism has been investigated extensively. The modern trend is to consider everything from the dynamic aspect, and therefore investigators using radioactive isotopes have followed the metabolic processes of many of these substances. In the animal it has been shown by Waelsch 
69-0% 80-4%
Results in g.l100 g. fresh tissue except ganglioside, which is in g./100 g. dry tissue. resulted, nor have we been able as yet to obtain post-mortem confirmation of our opinions, apart from three cases, and these patients died more than six months after operation.)
A patient with a diagnosis of amaurotic family idiocy arrived at histologically and chemically showed typical histological lesions in the cerebral cortex, and these can be seen in Figs. 7 and 8 . The chemical examination revealed a marked increase of ganglioside in the absence of any evident loss of phospholipid or of demyelination (Table III) . Metachromatic leucodystrophy, which is familial, shows an altered appearance of the myelin pattern, for in the white matter there is metachromasia as illustrated in Fig. 9 , while the chemical findings are seen in Table IV . It is to be noted that there is a marked increase of hexosamine in the white matter, while there is also evidence of a moderate degree of demyelination. It must be mentioned that metachromatic deposits occur in the kidney, and examination of the urine reveals such metachromatic material, and this was indeed found in this patient.
Lastly, subacute leucoencephalitis of the inclusion body or Van Bogaert type shows some slight but definite chemical findings, and are shown in Table V . There is only slight demyelination without the presence of cholesterol ester but with a slight increase in hexosamine levels. Table VI shows the actual number of cases which have been examined chemically, and the groups of diseases into which they fall. Acetylcholine Hunt and Taveau in 1906 were the first to demonstrate that acetylation of choline (a substance known to Thudichum and obtained originally from phosphatide in bile, hence its name) resulted in a product of greatly increased pharmacological activity. Loewi demonstrated in 1921 that liberation of a substance now known as acetylcholine, but called by him " Vagusstoff," was present in the perfusing fluid of a frog's heart after stimulation of the vagus nerve. Sir Henry Dale in 1914 Dale in , 1929 Dale in , and 1933 ably described the various effects of acetylcholine, and in the last paper of 1933 introduced the terms "cholinergic " and "adrenergic." Loewi and Dale shared the Nobel prize in 1936. In 1911 Dale, in association with Barger, was the first to isolate histamine from animal tissues. However, he is best known for his work on acetylcholine, which was later followed by work on neostigmine. Considerable knowledge is now available concerning the synthesis and destruction of acetylcholine after its release at nerve endings and the conception of an acetylcholine cycle has been put forward. It was soon clear from experimental procedures that an enzyme must be present to convert acetylcholine into some less active form. Such an enzyme, cholinesterase, which has been found to be widely distributed in the body, can in fact break down acetylcholine to acetic acid and choline. Two main types of such an enzyme have been found and these have been called, in 1943, true and false cholinesterase, or specific or non-specific cholinesterase. Nachmansohn, who proposed the latter term in 1945, was also an able worker on acetylcholine.
These two cholinesterases have been found to act on different substrates, and are present in varying amounts in different organs and areas. True cholinesterase was found by Nachmansohn in 1939 to be located more in the cerebral cortex than in the cerebral white matter, while pseudocholinesterase was present to a greater extent in the white matter, as in fact was shown by Ord and Thompson in 1952.
After release of acetylcholine at the nerve endings and its hydrolysis some process must then be present for its resynthesis. Quastel and his co-workers in 1936 suggested such a process, and it has since been proved that acetylcoenzyme A provides the acetyl group which is transferred to choline by the action of the enzyme choline acetylase. Acetyl-coenzyme A is probably derived from pyruvate, which links this mechanism, therefore, with the glucose cycle.
Only one or two applications of these findings to clinical neurology will be mentioned. Much biochemical work on epilepsy has been done at Montreal led by Elliott. Elliott and Tower in 1952 estimated bound acetylcholine and cholinesterase in normal portions of brain and in epileptogenic areas of brain, and found that in the latter there was a marked reduction of bound acetylcholine. Further work both by Elliott in Montreal and by Tower in Bethesda has followed, but it is too early to state its final practical value. Elliott has recently reported on y amino-butyric acid which is present in brain tissue, and has said that both glutamate and y amino-butyric acid may be " action substances " of neurophysiological importance, and that from his experimental results there may be a balance of effects of these two substances, and that they may determine neuronal activity.
The other condition I wish to mention is ginger paralysis. This is a form of motor neuritis first seen in the United States in 1930 following the drinking of a beverage containing an extract of Jamaica ginger. This was later found to contain tri-ortho-cresyl phosphate (T.O.C.P.). Various degenerative lesions were found in axis cylinders and in the myelin sheath in not only the peripheral neuritis mentioned but also after poisoning by T.O.C.P. present in other substances such as apiol and in certain cooking oils. The hen can be used as an experimental animal, and work has been done since 1950 on this subject by a number of experimenters. Earl and Thompson in 1952 showed that T.O.C.P. was a selective inhibitor of pseudocholinesterase in nervous tissue and in plasma but that true cholinesterase was unaffected. Certain new organophosphorus insecticides are also similarly dangerous, for parathion and mipafox both cause plasma and erythrocyte cholinesterases to be lowered. These last compounds do not, however, produce paralysis or degenerative lesions of nerve.
It is perhaps of interest to notice here that amongst some of these substances recently produced is one for locust control, and experimental work on this has just been published showing the effect of such substances on cholinesterases in the nerve cells of locusts.
So far an attempt has been made to show that our understanding of disease processes has followed a fairly definite pattern, and has stemmed from basic chemical work. Application of such basic knowledge has been applied to suitable patients with varying diseases in order to elucidate the cause and the nature of the pathological lesion involved. However, we now come to a group of disorders in which the reverse procedure has been followed. In patients with some diseases, abnormal chemical findings were first discovered, and, following this, basic chemical knowledge had to be determined. In 1908 Sir Archibald Garrod delivered the Croonian lectures at the Royal College of Physicians and his subject was " Inborn Errors of Metabolism." There are now known to be a number of such disorders, and one or two of them will be mentioned and an indication as to how progress has been made in our knowledge of these diseases.
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Having discovered a chemical abnormality in the patient, other workers in the past decade proceeded to determine the metabolic pathways that could be involved to produce this abnormality. The fundamental disorder appears to be that the inborn error is one concerned with a failure to metabolize phenylalanine along the normal pathways. In the normal subject phenylalanine is changed in the body into tyrosine by means of an enzyme, phenylalanine hydroxylase. In the patient with this disease this step is not possible, and phenylalanine circulates in the blood and is disposed of as phenylpyruvic acid and phenyllactic acid. There also appears to be an abnormality involving indoles and tryptophane. An attempt has recently been made to treat these patients by dietary restriction of phenylalanine, but this should be done in the first few weeks of life. The patients are given a casein hydrolysate which is freed of phenylalanine, tyrosine, and tryptophane.
Acute porphyria is another condition in which abnormal metabolic pathways have been shown to exist by Rimington. This condition is sometimes associated with a polyneuritis, and I have had the opportunity of seeing and examining a number of such neurological patients.
The third condition I wish to mention is hepatolenticular degeneration, which is now regarded as due to an inborn error of metabolism, for this disease appears to be associated with a disordered copper metabolism. Again the initial observations were made in patients with this disease, for it was discovered by Rumpel that copper and silver appeared to be deposited in the tissues. shows the results obtained. One of those treated is alive after eight years, and a number lived at least five years. As far as is known, two have married, and a few have been able to work again. Only two are known to have died, and each of these developed a severe cirrhosis of the liver; a portal caval shunt operation was performed and later both died in hepatic coma. The copper content of the liver in both cases, and the brain in one case, was within normal limits, thereby demonstrating the effectiveness of the treatment as far as the copper deposits were concerned. Neurologically, too, they were still improved before death, but the cirrhosis of the liver had advanced relentlessly. This review is very incomplete, only a few subjects having been mentioned, but it may be that it demonstrates the evolving pattern of the biochemistry of the nervous system and the value of basic research when applied to clinical practice.
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